Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study

Author:

Ueda Eiko12,Toya Yoshiyuki1,Wakui Hiromichi1,Ishiga Kohei1,Kawai Yuki12,Kobayashi Ryu1,Kinguchi Sho1,Kanaoka Tomohiko1,Saigusa Yusuke3,Mikami Taro4,Yabuki Yuichiro4,Goda Motohiko5,Machida Daisuke5,Fujita Takayuki6,Haruhara Kotaro7,Sugano Teruyasu1,Azushima Kengo1,Tamura Kouichi1

Affiliation:

1. Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine

2. Department of Medicine, Yokohama City University Medical Center

3. Department of Biostatistics, Yokohama City University School of Medicine

4. Department of Plastic and Reconstructive Surgery, Yokohama City University Hospital

5. Department of Cardiovascular Surgery, Yokohama City University

6. Department of Physiology, Fukuoka University School of Medicine

7. Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine

Publisher

Japan Atherosclerosis Society

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Treating PAD Patients with Lipoprotein Apheresis;Journal of Atherosclerosis and Thrombosis;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3